RG-002 (RinuaGene Biotechnology)

N/A

Report date: 2026/05/13 09:07:56

Base Information

Drug NameRG-002 (RinuaGene Biotechnology)
Drug Alias NamemRNA-LNP (RinuaGene Biotechnology)RG-002RG002
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > mRNA vaccineVaccines > Application > Therapeutic vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsSquamous Intraepithelial LesionsCervical Intraepithelial NeoplasiaPapillomavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesRenjing (Suzhou) Biotechnology Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesRenjing (Suzhou) Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsSquamous Intraepithelial LesionsCervical Intraepithelial NeoplasiaPapillomavirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A